Zydus gets USFDA nod for drug used treat knee osteoarthritis Ruby Khatun Khatun21 April 2018 10:15 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Diclofenac Sodium Topical Solution, used for treating signs...
AstraZeneca wins US approval for 1st-line use of lung cancer drug Ruby Khatun Khatun21 April 2018 9:45 AM ISTU.S. regulators have expanded use of AstraZeneca’s lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic...
GSK flags pharma Merger and Acquisition ambitions by poaching Roche deal-maker Ruby Khatun Khatun21 April 2018 9:30 AM ISTLONDON: GlaxoSmithKline (GSK) signaled its intention to boost its drug pipeline through deals on Wednesday by hiring Kevin Sin from Roche’s Genentech...
Glenmark gets USFDA nod for skin ointment Ruby Khatun Khatun20 April 2018 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Tacrolimus ointment used for treating atopic...
WHO recommends testing before use of Sanofi's dengue vaccine Ruby Khatun Khatun20 April 2018 10:30 AM ISTPARIS/CHICAGO: The World Health Organization (WHO) said Sanofi’s vaccine against dengue should only be used after testing on individuals to assess...
Rs 621 crore bank fraud: 3 pharma firm directors booked Ruby Khatun Khatun20 April 2018 10:15 AM ISTNew Delhi: The CBI has registered a case against Surya Pharmaceuticals, its directors and officials of three companies based in Dubai and Patiala for...
Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones Ruby Khatun Khatun20 April 2018 9:45 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the...
Roche's Hemlibra gets speedy FDA review for wider use Ruby Khatun Khatun20 April 2018 9:30 AM ISTZURICH: Roche’s hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the...
Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid Ruby Khatun Khatun19 April 2018 6:16 PM ISTNew Delhi: Fortis Healthcare said it has received an improved binding offer from Hero Enterprise Investment Office and Burman Family Office to invest...
FDA approves Crysvita for rare inherited form of rickets, x-linked hypophosphatemia Ruby Khatun Khatun19 April 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older...
Lupin gets tentative USFDA nod to market testosterone gel Ruby Khatun Khatun19 April 2018 10:00 AM ISTMumbai: Drug firm Lupin said it has received the tentative nod from the US health regulator to market its Testosterone gel 1.62 percent.The company...
AstraZeneca to invest 90 million dollars in India over next 5 years Ruby Khatun Khatun19 April 2018 10:00 AM ISTNew Delhi: Biopharmaceutical firm AstraZeneca said it will invest USD 90 million (around Rs 590 crore) in India over the next five years.The...
